New therapeutic strategies to treat human cancers expressing mutant p53 proteins
2018 · Journal of Experimental & Clinical Cancer Research · 210 citations
https://doi.org/10.1186/s13046-018-0705-7
S
Silvia Di Agostino
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
115
Papers
4.7K
Citations
39
h-index
58
i10-index
Silvia Di Agostino is an academic researcher from Magna Graecia University. The author has contributed to research in topics: Cancer-related Molecular Pathways & Hippo pathway signaling and YAP/TAZ & RNA modifications and cancer. The author has an h-index of 39, co-authored 98 publications.
ORCID: 0000-0003-3730-1125Papers by this author
worksReactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth
2016 · Cell Death and Differentiation · 97 citations
https://doi.org/10.1038/cdd.2016.48
The Mechanism of Docosahexaenoic Acid-induced Phospholipase D Activation in Human Lymphocytes Involves Exclusion of the Enzyme from Lipid Rafts
2002 · Journal of Biological Chemistry · 84 citations
https://doi.org/10.1074/jbc.m202376200
Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease
2024 · Leukemia · 8 citations
https://doi.org/10.1038/s41375-024-02168-z
HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis
2023 · Cell Death and Disease · 5 citations
https://doi.org/10.1038/s41419-023-06064-9
Arenavirus as a potential etiological agent of odontogenic tumours in humans
2020 · Journal of Experimental & Clinical Cancer Research · 4 citations
https://doi.org/10.1186/s13046-020-1540-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat